Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019840 |
---|---|
Receipt number | R000022902 |
Scientific Title | Treatment of Children with All Stage of Hepatoblastoma with Temsirolimus(IND#122782, NSC#683864) Added to High Risk Stratum Treatment |
Date of disclosure of the study information | 2015/11/18 |
Last modified on | 2024/01/25 12:26:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/18 13:15:26 | ||
2 | Update | 2015/12/01 15:20:41 | Institutions |
|
3 | Update | 2015/12/01 15:26:23 | Primary outcomes Primary outcomes |
|
4 | Update | 2016/07/07 17:24:45 | Name of primary person or sponsor Organization Organization Category of Funding Organization Institutions |
|
5 | Update | 2016/12/09 11:28:29 | Name of person sending information Name of person sending information Institutions |
|
6 | Update | 2017/01/26 09:14:48 | Organization |
|
7 | Update | 2017/01/26 09:16:00 | Organization |
|
8 | Update | 2017/04/05 14:58:37 | Organization Organization |
|
9 | Update | 2018/09/11 20:57:31 | Name of person sending information Name of person sending information |
|
10 | Update | 2018/09/11 20:58:06 | Recruitment status |
|
11 | Update | 2022/05/23 16:08:43 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Organization Address Address Tel |
|
12 | Update | 2022/05/23 16:22:54 | Zip code Organization1 Tel1 Organization Organization Address Tel |
|
13 | Update | 2023/11/24 08:37:29 | Number of participants that the trial has enrolled |
|
14 | Update | 2023/11/24 08:41:57 | Date of IRB Last follow-up date |
|
15 | Update | 2023/11/24 08:57:51 | Recruitment status |
|
16 | Update | 2024/01/25 12:26:24 | UMIN ID1 |